Rajiv Sancheti

Check out

[Rajiv Sancheti @sanchetio]

@designrivet Let’s goooo

[Rajiv Sancheti @sanchetio]

@gormankind @designrivet so excited about this launch

[Rajiv Sancheti @sanchetio]

@hyojun_at highest craft team out there

[Rajiv Sancheti @sanchetio]

insanely cool

[Nan Ransohoff @nanransohoff]

Today we're launching Intercept: a $500M philanthropic initiative to make respiratory infections, like the common cold and flu, a thing of the past.

We treat respiratory infections as a minor nuisance, but that’s really not the case. Most of us will spend 5% of our lives (!) sick from these viruses, they kill 1M people a year, cost $600B annually in productivity, and periodically threaten civilization through pandemics.

So, if they’re such a big problem, why haven’t we dealt with them yet? Last year we convened ~40 leading scientists, pharma R&D leaders, biotech investors, and regulatory experts to better understand that.

We heard two main reasons:
(1) First, it’s just technically very challenging: respiratory viruses represent hundreds of distinct, mutating strains across several families. Fortunately, recent breakthroughs make this newly possible.
(2) Second is a lack of funding: broad-spectrum solutions have historically been underfunded, in part because they’re not a great fit for most philanthropic or commercial funding (and while COVID generated a burst of activity around preventing and understanding respiratory infections through an influx of new funding, that hasn't been sustained).

We think that with enough focus and funding, this might be solvable. Intercept is a $500 million philanthropic initiative that will take advantage of new tools to catalyze the development and deployment of two types of products: broad-spectrum preventatives and air cleaning technologies.

This problem is undoubtedly difficult. But it’s more tractable now than it’s ever been. We think we should give it our best shot.

We’re enormously grateful to our anchor funders: @stripe, @AnthropicAI, @TheFluLab, @FoundationOAI and individuals from Jane Street.

And, I’m very excited to be building this with @incredutility and the rest of the team.

[Rajiv Sancheti @sanchetio]

@ConnorWaslo sounds like a @chrstnctns clone

[Rajiv Sancheti @sanchetio]

dune harkonnens / mri collab

[Midjourney @midjourney]

Announcing a new division of Midjourney called "Midjourney Medical"

[Cooper @cooperbrown9]

This is the only feature I use and I work here
@try_caddy

[Rajiv Sancheti @sanchetio]

@aaron_epstein @golda @greybaker let’s goooo @greybaker

[Rajiv Sancheti @sanchetio]

why use more code when less code do trick

[Connor Waslo @ConnorWaslo]

how the companies that already closed their round show up to demo day

[Connor Waslo @ConnorWaslo]

okay new favorite Caddy use case

solo founder user has Caddy text him every morning asking his top 3 goals for the day

on fridays it rolls the whole week into a clean recap before he meets his advisor

literally 2 texts and you've got an accountability partner ready to go

[Rajiv Sancheti @sanchetio]

@gurishsharma this is so sick, congrats guys!

[Connor Waslo @ConnorWaslo]

a user just told me Caddy saved them $170k

they totally forgot about a scholarship deadline and Caddy pinged them with just a few hours to go

tbh my first thought was just “damn, we’re giving this away for free”

[Rajiv Sancheti @sanchetio]

@iamnotsrc @try_caddy appreciated the opportunity to work with you @iamnotsrc 🔥

[Cooper @cooperbrown9]

It literally just works

@try_caddy

[Rajiv Sancheti @sanchetio]

what people actually use ai for

[Connor Waslo @ConnorWaslo]

need more testimonials like this

appreciate you @samrathchadha

[Rajiv Sancheti @sanchetio]

@imanradjavi @imanradjavi you’re the man

[Connor Waslo @ConnorWaslo]

Today we’re launching Caddy to public beta.

We think AI should work just like a caddy: it carries your heavy shit, gives advice, and take work off your plate so that you can focus on what matters.

It lives in your iMessage and helps you stay on top of work and life without opening another app.

Give it a try.